MangoceuticalsMGRX
那斯達克 · USD
0.49
+0.12
(+31.70%)
收盤 03/28 03:59 (UTC+8)
盤後
0.45
0.45
(-7.92%)
03/28 03:59 (UTC+8)
MangoceuticalsMGRX
0.49
+0.12
(+31.70%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 39.60
- 73.76
- -0.41
- -12.30
- -23.83
- -18.40
- -21.05
- 3.81
- 54.13
- -50.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 84 | 168 | 109 | 105 | 133 | 163 | 214 | 244 | 245 | 141 |
營業成本 | 33 | 78 | 47 | 25 | 51 | 93 | 67 | 102 | 101 | 54 |
營業毛利 | 51 | 90 | 62 | 80 | 83 | 70 | 147 | 143 | 145 | 87 |
營業費用 | 7,594 | 5,358 | 4,915 | 1,758 | 1,841 | 2,238 | 2,515 | 2,711 | 1,944 | 3,547 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 7,594 | 5,358 | 4,915 | 1,758 | 1,841 | 2,238 | 2,515 | 2,711 | 1,944 | 3,547 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,543 | -5,268 | -4,853 | -1,678 | -1,758 | -2,169 | -2,368 | -2,568 | -1,799 | -2,292 |
其他收入及費用 | - | -126 | - | -722 | - | - | - | 6 | - | - |
利息費用 | 76 | 22 | -14 | -451 | 242 | 223 | - | 6 | - | -8 |
稅前純益 | -7,619 | -5,416 | -4,839 | -1,949 | -2,000 | -2,391 | -2,368 | -2,568 | -1,799 | -2,284 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -7,618 | -5,416 | -4,839 | -1,948 | -1,999 | -2,391 | -2,368 | -2,568 | -1,799 | -2,284 |
基本每股稅後盈餘(元) | -0.69 | -0.57 | -1.29 | - | -0.08 | -0.09 | -0.10 | - | -0.11 | -0.14 |
稀釋每股稅後盈餘(元) | -0.56 | -0.57 | -1.29 | -0.56 | -0.09 | -0.09 | -0.10 | -0.13 | -0.12 | -0.10 |
基本平均股數(千股) | 11524.00 | 9983.00 | 4593.00 | - | 30207.00 | 26099.00 | 23619.00 | - | 15923.00 | 15772.00 |
稀釋平均股數(千股) | 11524.00 | 9983.00 | 4593.00 | - | 30207.00 | 26099.00 | 23619.00 | - | 15923.00 | 15772.00 |
還原基本每股稅後盈餘(元) | -0.69 | -0.57 | -1.29 | - | -1.14 | -1.37 | -1.50 | - | -1.70 | -2.10 |
還原稀釋每股稅後盈餘(元) | -0.56 | -0.57 | -1.29 | -0.56 | -1.38 | -1.35 | -1.50 | -1.90 | -1.73 | -1.50 |
還原基本平均股數(千股) | 11,524 | 9,983 | 4,593 | - | 2,013 | 1,739 | 1,574 | - | 1,061 | 1,051 |
還原稀釋平均股數(千股) | 11,524 | 9,983 | 4,593 | - | 2,013 | 1,739 | 1,574 | - | 1,061 | 1,051 |
EBITDA(千元) | -7,517 | -4,558 | -4,438 | -2,142 | -1,544 | -1,942 | -2,362 | -2,556 | -1,793 | -2,286 |